- Advertisement
FAQ
- What is Genome Medicine?
- Why submit to Genome Medicine?
- What is open access?
- If my article is published, how will it be cited?
- If my article is published, which bibliographic databases will it be indexed in?
- How much of the content on the website is available for free?
- How can I order reprints?
- What is the copyright policy of Genome Medicine?
- Do I need permission to reproduce materials published in Genome Medicine?
- What are the benefits of registering on the journal website?
- Is there a printed version of the journal?
- What is BioMed Central?
- What is the peer-review process for Genome Medicine?
- How quickly will my research article be published in Genome Medicine?
-
What is Genome Medicine?
Genome Medicine is an online peer-reviewed journal which publishes open access research articles of outstanding quality in all areas of medicine studied from a genomic or post-genomic perspective. The journal has a special focus on the latest technologies and findings that have an impact on the understanding and management of human health and disease.
All articles are available online, and in addition the website offers many other services:
- Quick and advanced search facilities.
- RSS feed, to deliver our latest articles directly to your news headline reader.
- Email articles directly to your friends and colleagues.
- Post a comment on an article, to add your opinion.
For details of the scope and types of article published by Genome Medicine see About Genome Medicine
-
Why submit to Genome Medicine?
Submit your research to Genome Medicine to take advantage of :
Rapid peer review
Our insistence on fast and thorough peer review enables us to process manuscripts quickly; we aim to reach initial decisions within four weeks.
Publication immediately on acceptance
All articles are published and receive their final citation details on the day they are accepted. Fully copy-edited and formatted versions of the article replace the accepted manuscript within 4 weeks. Within 48 hours of publication, your article will be listed in PubMed, bringing your work to its intended audience as quickly as possible.
Open access
All research articles published in Genome Medicine are open access (freely available on the journal website, with the copyright retained by the author). Research articles are deposited in at least one widely and internationally recognized open access repository such as PubMed Central, complying with the NIH Public Access Policy and the Wellcome Trust Open Access Policy. To cover the cost of open access publishing we levy an article-processing charge.
High visibility within the field
Your work is freely accessible to a global audience. In addition, articles are available through PubMed Central, and are listed/indexed by PubMed the US National Library of Medicine's full-text repository of life science literature, at INIST in France and in e-Depot, the National Library of the Netherlands' digital archive of all electronic publications. We are also in discussion with other permanent digital archives including the British Library.
Permanence
All articles published in Genome Medicine are archived in a number of safe open access archives so permanent accessibility is assured.
-
What is open access?
All research articles published in Genome Medicine are open access, which means they are freely and universally accessible online, and permanently archived in an internationally recognised open access repository.
Article-processing charges
As the cost of peer reviewing, editing, publishing, maintaining and archiving articles is not recouped through subscription charges, a standard article-processing charge (APC) is levied on all articles that are accepted for publication. The APC is a flat charge, and no additional costs are incurred, for example, by the inclusion of color figures. The current APC for Genome Medicine is £1525/$2380/€1860.
Our publisher, BioMed Central, operates a membership scheme, whereby authors submitting from member institutions have their APC covered in full or in part by their institution. Please click here to check if your institution is a BioMed Central member. If you would like your institution to become a member of BioMed Central, please fill out our recommendation form to suggest this to the relevant person in your organization.
You may be aware that an increasing number of funding agencies strongly encourage open access publication and explicitly allow the use of grants to cover APCs. Some, such as the Wellcome Trust, insist that all research funded by them is open access on publication. Please click here for more information.
In cases where neither the authors nor their institution or funder are able to pay the APC, a discount or waiver may be granted. There is currently an automatic waiver for authors from low or lower-middle income countries (according to World Bank criteria). Requests for waivers should be made as part of the online submission process.
Benefits of open access
- Open access articles are freely available via the Internet and are therefore more widely visible than articles published behind subscription barriers, with some studies suggesting that on average open access articles are twice as likely to be cited.
- Retaining copyright means that authors can reproduce and distribute their work as they choose, for example on their institution's website.
- Open access publication benefits the scientific community by making results of research immediately and freely available to all.
-
If my article is published, how will it be cited?
Articles in Genome Medicine should be cited in the same way as articles in a traditional journal. However, because articles in this journal are not printed, they do not have page numbers. Instead, they have a unique article number.
The following citation:
Genome Med 2005, 6:306
refers to article 306 from volume 6 of the journal.
As an online journal, Genome Medicine does not have issue numbers. Each volume corresponds to a calendar year.
-
If my article is published, which bibliographic databases will it be indexed in?
All articles published in Genome Medicine are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Genome Medicine include:
The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including INIST (France) and e-Depot (The Netherlands).
-
How much of the content on the website is available for free?
All research articles published in Genome Medicine are open access, which means they are freely and universally accessible online, immediately upon publication.
All content in the journal's correspondence section is also free to access.
All Minireviews, full-length Reviews, Commentary and Meeting report articles require registration.
-
How can I order reprints?
As all research articles are open access, readers are free to download and/or print copies from the website, according to the terms of the Creative Commons Attribution License.
If, however, you require high quality, bound reprints of research articles, BioMed Central (Genome Medicine's publisher) offers a fast, professional reprint service, and reprints can be ordered by contacting commercialreprints@biomedcentral.com.
Authors can order reprints of their own articles published in Genome Medicine or any other BioMed Central journal, by logging on to http://www.biomedcentral.com/my/manuscripts or by sending an email to reprints@biomedcentral.com
-
What is the copyright policy of Genome Medicine?
All research articles published in Genome Medicine are open access, which means the articles are universally and freely available online. In addition, the authors retain copyright of their article, and grant any third party the right to use reproduce and disseminate the article, subject to the terms of our copyright and license agreement. Allowing the authors to retain copyright of their work permits wider distribution of their work on the condition it is correctly attributed to the authors.
For non-research articles authors retain the copyright of their article, but they grant BioMed Central, Genome Medicine's publisher, an exclusive license to publish this article for two years, after which the license becomes non-exclusive. During this period BioMed Central has the exclusive right to publish, translate, make summaries and other derivatives, and license others. For further details, please refer to our copyright licensing agreement for non-research articles.
-
Do I need permission to reproduce materials published in Genome Medicine?
Illustrations, figures or tables from research articles may be reproduced in any format or medium, provided that BioMed Central is duly identified as the original publisher, and that proper attribution of authorship and correct citation details are given, in accordance with BioMed Central's Open Access Charter.
For all other articles, please contact permissions@biomedcentral.com with relevant details, or send a fax or letter to: BioMed Central, Reprints & Permissions Department, Floor 6, 236 Gray's Inn Road, London, WC1X 8HB, UK. Fax: +44 (0)20 3192 2000.
-
What are the benefits of registering on the journal website?
By registering your details with Genome Medicine you can elect to receive regular article alerts to stay up to date with the latest content either every time an new article is published, or on a weekly, fortnightly or monthly basis. You can also choose to receive updates of the latest news about this, and other journals published by BioMed Central.
Genome Medicine's personalized alert service lets you know about newly published material that is of interest to you, aiming to provide you with the information and resources you need, customized to your preferences. Our aim is to be your preferred gateway into the world of post-genomic medicine.
Registration is required for submitting a manuscript to Genome Medicine.
-
Is there a printed version of the journal?
Genome Medicine is published online only. If you wish to print out a copy of an article, we recommend you select the PDF version of the article online. PDFs of all articles have been formatted in a way that is ideal for printing, so, if you prefer, articles don't have to be read on screen.
-
What is BioMed Central?
BioMed Central is an independent publishing house committed to providing immediate open access to peer-reviewed biological and medical research. BioMed Central publishes online, open access journals covering all fields in biology and medicine - from life sciences and ecology to clinical medicine. All of the original research articles in journals published by BioMed Central are immediately and permanently available online without charge or any other barriers to access. BioMed Central views open access to research as essential to rapid and efficient communication of research findings. BioMed Central is committed to maintaining high standards through full and stringent peer review. Authors who publish original research articles in journals published by BioMed Central retain copyright over their work. BioMed Central supports PubMed Central and other digital repositories, and encourages self-archiving by authors. BioMed Central, Chemistry Central and PhysMath Central are part of Springer Science+Business Media.
-
What is the peer-review process for Genome Medicine?
All research articles undergo peer review. Submitted manuscripts are subject to immediate screening by Genome Medicine's in-house Editorial Team and manuscripts that do not meet the standards of the journal may be declined without further review or considered for another journal in the BMC series.
Appropriate manuscripts will be sent to up to 4 independent referees (most manuscripts are peer-reviewed by 2-3 independent experts), who have agreed in advance to referee rapidly. The editorial team makes every effort to give the authors a decision within four weeks.
Referees are asked to declare any competing interests they may have in reviewing a manuscript.
All peer review is closed - authors are not given the names of the reviewers of their manuscript, unless the referee elects to sign his/her report.
If an author is not satisfied with the decision made on their manuscript, they are able to contact the editorial office with an appeal. A second opinion on the manuscript will be sought where appropriate.
-
How quickly will my research article be published in Genome Medicine?
The Genome Medicine editorial team aims to give authors an initial decision on their manuscript within four weeks of submission, and manuscripts are typically published within 3 months of submission.